Repurposing an ADHD Drug for Alzheimer’s Disease
A recent clinical trial suggests new promise for the use of an ADHD drug, atomoxetine, in reducing biomarkers associated with Alzheimer’s…
The Encyclopedia of Science's Frontier
A recent clinical trial suggests new promise for the use of an ADHD drug, atomoxetine, in reducing biomarkers associated with Alzheimer’s…
A large trial of COVID-19 positive patients at increased risk of severe illness showed that two types of monoclonal antibody infusions did…
A landmark clinical trial was announced recently by researchers at Kyoto University. For the first time in history, this trial tests the use…
For most types of cancer, survival rates have steadily been improving since the 1970s as medical advancements have been made in both cancer…